Cannabidiol (CBD) for diabetes: New hope for the treatment of aphthae and poorly healing oral wounds

Diabetes mellitus is one of the most common chronic metabolic diseases worldwide. It is characterized by a persistently elevated blood sugar level, which causes numerous long-term health complications. While most people associate diabetes with secondary diseases such as cardiovascular diseases, nerve damage, or kidney diseases, the effects on oral health are often underestimated. A common but often distressing complication are aphthae, i.e., painful ulcers of the oral mucosa. Especially in people with diabetes mellitus, these lesions can heal more slowly and significantly impair quality of life. New scientific findings suggest that cannabidiol (CBD) could represent a promising supportive therapy.
A recent scientific article in the journal Anais da Academia Brasileira de Ciências investigates whether CBD can modulate inflammation and promote the healing of oral wounds in people with diabetes.

Why do wounds heal worse in diabetes?

People with diabetes mellitus often suffer from impaired wound healing. The main reason for this is chronic hyperglycemia, i.e., a persistently elevated blood sugar level.

The role of Advanced Glycation End-Products (AGEs)

High blood sugar levels lead to the formation of so-called Advanced Glycation End-Products (AGEs). These compounds are formed when sugar reacts with proteins or fats. The consequences are far-reaching:

• Stiffening of the tissue
• Chronic inflammatory reactions
• Impairment of collagen formation
• Delayed regeneration of skin and mucous membranes

In addition, AGEs activate important inflammatory pathways such as:

1. NF-κB signaling pathway
2. MAPK signaling pathway

These processes promote the release of pro-inflammatory mediators and significantly worsen wound healing.

Aphthae in diabetes: An underestimated problem

Aphthae are small, painful ulcers of the oral mucosa. They can:

• make eating difficult,
• impair speaking,
• make oral hygiene difficult,
• significantly reduce quality of life.

The prevalence of aphthae in the population ranges between 5 and 66 percent according to studies. However, people with diabetes mellitus have an increased risk of:

• more frequent inflammations,
• longer healing times,
• recurring oral lesions.

The reason lies in the impaired immune response and reduced tissue regeneration.

What is cannabidiol (CBD)?

Cannabidiol (CBD) is one of the most important active compounds of the plant Cannabis sativa. Unlike THC, CBD has no intoxicating effect. In recent years, research has identified numerous potential properties of CBD:

• anti-inflammatory,
• antioxidative,
• immunomodulatory,
• analgesic,
• wound healing promoting.

These properties make CBD an interesting candidate for the treatment of chronic inflammations and poorly healing wounds.

How does CBD work on oral ulcers and aphthae?

Inhibition of inflammation

Studies show that CBD reduces the production of pro-inflammatory cytokines, including:

• IL-1β
• IL-6
• TNF-α

These mediators play a crucial role in the development of chronic inflammation. At the same time, CBD inhibits the NF-κB signaling pathway, which is particularly active in diabetic inflammatory processes.

Promotion of wound healing

Researchers observed that CBD:

• promotes the formation of new blood vessels,
• stimulates the proliferation of fibroblasts,
• improves collagen formation,
• accelerates re-epithelialization.

These processes are essential for successful tissue healing and are often limited in people with diabetes mellitus.

What do scientific studies say?

Animal studies provide promising results

In a study by Klein and colleagues, standardized aphthae were induced in rats and subsequently treated with CBD. The results showed:

1. significantly fewer inflammatory cells,
2. reduced cytokine levels,
3. faster wound healing.

Another study by Qi and co-workers confirmed these results. The topical application of CBD led to:

• stronger collagen deposition,
• faster tissue restoration,
• improved regeneration of the mucosa.

Molecular mechanisms of action

Particularly interesting is the influence of CBD on the so-called CMPK2-mediated NLRP3 inflammasome. By inhibiting this inflammation system, CBD reduces:

• the activation of caspase-1,
• the release of IL-1β,
• oxidative stress in the tissue.

Furthermore, CBD activates the PPARγ signaling pathway, which supports cell regeneration and the formation of new tissue structures.

Clinical studies in humans

Not only animal studies provide positive results. Randomized clinical trials also show promising outcomes. A 0.1 percent CBD formulation was able to:

• significantly reduce the size of aphthae,
• decrease inflammation,
• shorten healing time.

Particularly noteworthy: no relevant side effects were observed. These results suggest that CBD could become a valuable addition to the treatment of aphthae and other inflammatory oral lesions in the future.

Could CBD be an alternative to corticosteroids?

Currently, corticosteroids are considered the standard therapy for recurrent aphthae. However, they are not free of side effects:

• fungal infections in the mouth,
• mucosal irritation,
• long-term tissue changes.

Here, cannabidiol (CBD) could in the future represent an interesting supplement or possibly even an alternative. However, scientists emphasize that further studies are necessary to:

• determine the optimal dosage,
• assess long-term safety,
• conduct direct comparisons with corticosteroids.

What does this mean for people with diabetes?

Current research findings show that CBD has the potential to:

• reduce inflammation
• accelerate wound healing
• lower oxidative stress
• promote tissue regeneration

Especially for people with diabetes mellitus, who often suffer from poorly healing wounds and recurrent aphthae, this could open up new therapeutic possibilities in the future. Nevertheless, the use of CBD should always be discussed with the treating physician, especially in the case of existing diseases or the use of other medications.

Conclusion

Research on cannabidiol (CBD) and diabetes mellitus is still in an early stage, but the results so far are promising. Both preclinical and clinical studies show that CBD can modulate inflammatory processes and promote the healing of aphthae as well as other oral lesions. For people with diabetes, CBD could in the future represent an innovative complementary therapy option – especially for chronic inflammations and poorly healing wounds of the oral mucosa. However, before broad medical use can be recommended, further high-quality clinical studies are required.

FAQ: CBD in diabetes and aphthae

What are aphthae and why do they occur more frequently in diabetes?

Aphthae are painful inflammations of the oral mucosa. In diabetes mellitus, elevated blood sugar levels can impair immune defense and wound healing, causing oral ulcers to occur more frequently and heal more slowly.

Can CBD help with aphthae and oral wounds?

Current studies suggest that cannabidiol (CBD) has anti-inflammatory and wound healing promoting properties. It could support the healing of aphthae and reduce inflammatory processes in the oral mucosa. However, further clinical studies are needed.

How does CBD affect wound healing?

CBD can inhibit the release of pro-inflammatory mediators, reduce oxidative stress, and support collagen formation as well as tissue regeneration. These processes are especially important for people with diabetes, as wound healing is often slowed down.

Is CBD oil allowed in diabetes?

In many European countries, CBD oils with a legally permitted THC content are freely available. However, legal regulations may vary depending on the country. Before use, consumers should consider the applicable regulations and possible interactions with medications.

Can CBD oil be used for oral complaints?

A high-quality CBD oil is appreciated by many users as a natural supplement to support overall well-being. Those interested in learning more about various CBD oils and their properties can find further information and suitable options in our product section.

Does CBD replace treatment by a doctor?

No. CBD should not be seen as a substitute for medical treatment or prescribed medications. In cases of recurrent aphthae, diabetes, or other health complaints, medical evaluation is always recommended.

Note: The current state of research on CBD in diabetes and aphthae is promising but not yet conclusive. Statements about effects refer to scientific investigations and do not replace individual medical advice.

Sources:
Moura PHM, Silva DMRR, Lisboa LRS et al. Can cannabidiol be effective in modulating inflammation and enhancing oral healing in diabetes mellitus? Anais da Academia Brasileira de Ciências. 2025;97(Suppl.4). DOI: 10.1590/0001-3765202520250931.
Antar SA, Ashour NA, Sharaky M et al. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomedicine & Pharmacotherapy. 2023;168:115734.
Klein M, de Quadros De Bortolli J, Guimarães FS et al. Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation. Phytotherapy Research. 2018;32(11):2275–2281. DOI: 10.1002/ptr.6165.

Images: ChatGPT